1st Circuit Affirms Dismissal Of Securities Fraud Case Over Alleged Half-Truths
BOSTON — A First Circuit U.S. Court of Appeals panel affirmed a lower court’s dismissal of investors’ case against a biopharmaceutical company, holding that investors had no actionable securities fraud claim...To view the full article, register now.
Already a subscriber? Click here to view full article